Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

Izidore Lossos, Debra K. Czerwinski, Ash A. Alizadeh, Mark A. Wechser, Rob Tibshirani, David Botstein, Ronald Levy

Research output: Contribution to journalArticle

674 Citations (Scopus)

Abstract

BACKGROUND: Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS: We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS: In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS: Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.

Original languageEnglish
Pages (from-to)1828-1837
Number of pages10
JournalNew England Journal of Medicine
Volume350
Issue number18
DOIs
StatePublished - Apr 29 2004

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Gene Expression
Survival
Transcriptome
Genes
Real-Time Polymerase Chain Reaction
Lymphoma
Genome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lossos, I., Czerwinski, D. K., Alizadeh, A. A., Wechser, M. A., Tibshirani, R., Botstein, D., & Levy, R. (2004). Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. New England Journal of Medicine, 350(18), 1828-1837. https://doi.org/10.1056/NEJMoa032520

Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. / Lossos, Izidore; Czerwinski, Debra K.; Alizadeh, Ash A.; Wechser, Mark A.; Tibshirani, Rob; Botstein, David; Levy, Ronald.

In: New England Journal of Medicine, Vol. 350, No. 18, 29.04.2004, p. 1828-1837.

Research output: Contribution to journalArticle

Lossos, I, Czerwinski, DK, Alizadeh, AA, Wechser, MA, Tibshirani, R, Botstein, D & Levy, R 2004, 'Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes', New England Journal of Medicine, vol. 350, no. 18, pp. 1828-1837. https://doi.org/10.1056/NEJMoa032520
Lossos, Izidore ; Czerwinski, Debra K. ; Alizadeh, Ash A. ; Wechser, Mark A. ; Tibshirani, Rob ; Botstein, David ; Levy, Ronald. / Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. In: New England Journal of Medicine. 2004 ; Vol. 350, No. 18. pp. 1828-1837.
@article{b79f987637e24cab8a3544cea6ec3642,
title = "Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes",
abstract = "BACKGROUND: Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS: We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS: In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS: Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.",
author = "Izidore Lossos and Czerwinski, {Debra K.} and Alizadeh, {Ash A.} and Wechser, {Mark A.} and Rob Tibshirani and David Botstein and Ronald Levy",
year = "2004",
month = "4",
day = "29",
doi = "10.1056/NEJMoa032520",
language = "English",
volume = "350",
pages = "1828--1837",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "18",

}

TY - JOUR

T1 - Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes

AU - Lossos, Izidore

AU - Czerwinski, Debra K.

AU - Alizadeh, Ash A.

AU - Wechser, Mark A.

AU - Tibshirani, Rob

AU - Botstein, David

AU - Levy, Ronald

PY - 2004/4/29

Y1 - 2004/4/29

N2 - BACKGROUND: Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS: We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS: In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS: Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.

AB - BACKGROUND: Several gene-expression signatures can be used to predict the prognosis in diffuse large-B-cell lymphoma, but the lack of practical tests for a genome-scale analysis has restricted the use of this method. METHODS: We studied 36 genes whose expression had been reported to predict survival in diffuse large-B-cell lymphoma. We measured the expression of each of these genes in independent samples of lymphoma from 66 patients by quantitative real-time polymerase-chain-reaction analyses and related the results to overall survival. RESULTS: In a univariate analysis, genes were ranked on the basis of their ability to predict survival. The genes that were the strongest predictors were LMO2, BCL6, FN1, CCND2, SCYA3, and BCL2. We developed a multivariate model that was based on the expression of these six genes, and we validated the model in two independent microarray data sets. The model was independent of the International Prognostic Index and added to its predictive power. CONCLUSIONS: Measurement of the expression of six genes is sufficient to predict overall survival in diffuse large-B-cell lymphoma.

UR - http://www.scopus.com/inward/record.url?scp=2342587416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342587416&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa032520

DO - 10.1056/NEJMoa032520

M3 - Article

C2 - 15115829

AN - SCOPUS:2342587416

VL - 350

SP - 1828

EP - 1837

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 18

ER -